Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | 0 | Antiviral activity against HIV1 RF in CEM-SS cells by XTT assay | ChEMBL. | 17579385 |
Activity (functional) | 0 | Antiviral activity against HIV1 3B in MT4 cells by MTT assay | ChEMBL. | 17579385 |
Activity (functional) | 0 | Antiviral activity against HIV2 ROD in MT4 cells by MTT assay | ChEMBL. | 17579385 |
CC50 (ADMET) | = 5.2 uM | Cytotoxicity against mock-infected CEM-SS cells | ChEMBL. | 17579385 |
CC50 (ADMET) | = 5.2 uM | Cytotoxicity against mock-infected CEM-SS cells | ChEMBL. | 17579385 |
CC50 (ADMET) | = 16.8 uM | Cytotoxicity against mock-infected MT4 cells | ChEMBL. | 17579385 |
CC50 (ADMET) | = 16.8 uM | Cytotoxicity against mock-infected MT4 cells | ChEMBL. | 17579385 |
IC50 (binding) | > 100 uM | Inhibition of HIV1 recombinant reverse transcriptase | ChEMBL. | 17579385 |
IC50 (binding) | > 100 uM | Inhibition of HIV1 recombinant reverse transcriptase | ChEMBL. | 17579385 |
t1/2 (ADMET) | 0 | Metabolic stability in rat plasma | ChEMBL. | 17579385 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.